Please assess the completion status of the following clinical trial:

Trial Title: Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female (post menopausal and/or surgically sterile)~* Aged 18 to 70 years~* Treatment naïve subjects with fasting blood glucose levels of 150-220 mg/dL, hematocrit of \>/= 35% and HbA1c levels of \>/= 7% and \</= 10.0%~* Subjects on antidiabetic therapy with fasting blood glucose levels of 100-200 mg/dL, hematocrit of \>/= 35%, and HbA1c levels of \>/= 6.5% and \</= 9.0%~Exclusion Criteria:~* Greater than 3 severe hypoglycemic episodes within six months of screen~* Pregnant, breastfeeding, or intends to become pregnant~* Clinical signs or symptoms of liver disease, acute or chronic hepatitis, or ALT greater than 1.5 times the upper limit of normal~* History of hepatitis B surface antigen, hepatitis C antibody, or HIV~* Complications of diabetes (e.g., neuropathy, nephropathy, and retinopathy)~* Clinically significant and currently active diseases~* Clinically significant abnormalities in medical history, physical examination, or laboratory examination

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).